Strength
300 mg/1
Manufacturer
AvPAKNDC
50268068015
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
OXCARBAZEPINEApproval Type
Generic (ANDA)
FDA Application
ANDA215939On Market Since
6/7/2023
Pharmacological Classes
Price Statistics
The NADAC for OXCARBAZEPINE 300 MG TABLET has been published 142 times since Oct 11, 2023, and over the history we have for it it has declined 14.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1664 per EA |
|---|---|
| All-time high | $0.2109 (Apr 10, 2024) |
| All-time low | $0.1454 (Nov 20, 2024) |
| 52-week high | $0.1757 |
| 52-week low | $0.1664 |
| Median price | $0.1753 |
| Average price | $0.1808 |
| Largest weekly change | +25.1% (Aug 21, 2024) |
| Weeks tracked | 142 |
| Tracking since | Oct 11, 2023 |
Generic Alternatives
The matcher finds 8 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 8 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of OXCARBAZEPINE 300 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for OXCARBAZEPINE 300 MG TABLET, manufactured by AvPAK, is $0.1664 per EA (NDC 50268068015), effective Jun 24, 2026.
How has the price of OXCARBAZEPINE 300 MG TABLET changed over time?
Over the history we have for it, the NADAC for OXCARBAZEPINE 300 MG TABLET has declined 14.4%. It has been tracked across 142 weekly CMS publications since Oct 11, 2023.
What are the highest and lowest recorded NADAC prices for OXCARBAZEPINE 300 MG TABLET?
Since Oct 11, 2023, the NADAC for OXCARBAZEPINE 300 MG TABLET has ranged from a low of $0.1454 (Nov 20, 2024) to a high of $0.2109 (Apr 10, 2024), with a median of $0.1753 per EA.
Are there cheaper alternatives to OXCARBAZEPINE 300 MG TABLET?
8 NADAC-published products share the same active ingredient, strength, and dosage form as OXCARBAZEPINE 300 MG TABLET, but none are currently priced below it.
Who manufactures OXCARBAZEPINE 300 MG TABLET?
OXCARBAZEPINE 300 MG TABLET (NDC 50268068015) is labeled by AvPAK, and CMS classifies it as a generic product.
Related Drugs
Same classification